• News
  • SAN DIEGO
  • Medical

Illumina completes acquisition of Verinata Health

San Diego-based Illumina Inc. (Nasdaq: ILMN) has completed its acquisition of Verinata Health Inc., a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities.

Verinata Health now becomes a wholly owned subsidiary of Illumina.

Illumina will have access to Verinata’s verifi prenatal test and to its intellectual property portfolio.

The verifi test will continue to be offered through Verinata’s CLIA- and CAP-accredited laboratory, and the company will continue to generate the clinical data necessary for future regulatory submissions.

User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
150.22
  -1.62  
- 1.07%
1,601,217,000
242.37
130.0

Insider Trade Data

Date Insider Shares Type Value
10/15/2015 Flatley, Jay T 10,000 Sell $1,500,000
10/15/2015 Flatley, Jay T 10,000 Exchange $279,700
10/15/2015 Flatley, Jay T 10,000 Sell $1,500,000
10/07/2015 Bradbury, Daniel M 1,700 Sell $247,878
10/07/2015 Bradbury, Daniel M 1,700 Exchange $75,667

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
NAICS - 541711 - Research and Development in Biotechnology